Summary
Introduction
Chronic constipation leads to a considerable loss of quality of life and increases healthcare costs. It is also a common reason for primary care visits and referrals to gastroenterologists.
The prevalence of constipation varies with the definition used.
The Rome III criteria (see Box 1) are a useful definition for
Box 1
Rome III criteria for chronic constipation 1 Presence of two or more of the following: n straining during at least 25% of bowel movements n lumpy or hard stools in at least 25% of bowel movements n sensation of incomplete evacuations for at least 25% of bowel movements n sensation of anorectal blockage for at least 25% of bowel movements n manual manoeuvres to facilitate at least 25% of bowel movements n fewer than three bowel movements each week.
Loose stools are rarely present without laxatives.
These criteria must have been present for the last three months, with symptom onset at least six months before diagnosis. 
Box 2

Constipation -alarm symptoms for more serious conditions
Assessment
Being alert to alarm symptoms (see Box 2) is important as they may point towards an underlying organic cause such as colorectal neoplasia, intestinal obstruction or inflammatory bowel disease. Chronic constipation in the absence of these alarm symptoms can still be due to other secondary causes. 
Non-drug treatment
Reassurance can be offered if there are no alarm symptoms.
Simple education about a normal stool habit may help. The timing of bowel motions should be as regular as possible.
Defecation should not be postponed unnecessarily when the urge arises. Patients can be reminded that colonic motility There is a reliable dose-response between fibre and water intake and stool bulk and frequency. A dietary history will determine whether there is sufficient fibre in the diet in the form of cereals, grains, and fruit and vegetables. Increasing dietary fibre to the recommended daily intake of approximately 30 g or the use of fibre supplements such as psyllium should help in those patients with fibre deficiency. Adequate daily fluid intake is also important to maximise the benefit of fibre. However, increasing fibre intake beyond the required amount results in bloating or flatulence in many patients without relieving constipation, and may even aggravate it. Similarly, merely increasing the daily fluid intake in the absence of adequate fibre will not improve constipation.
Box 3
Constipating drugs
Increasing physical activity can promote colonic motility, so an active lifestyle can be encouraged. As constipation may be exacerbated by stress and depression, these factors should be addressed if they are present.
Pharmacological measures
Many patients who present with constipation will have already tried a variety of non-prescription remedies. Enquire about the use of these remedies before deciding the best approach to treatment.
The numerous agents commonly used to treat constipation can be classified according to their mechanism of action ( Table 1) .
Their relative efficacy and tolerability has generally not been well studied. The choice of treatment is therefore based on the mechanism of action, required onset, duration of action and patient preference. Trial and error is often required to determine the optimal management plan. 
Bulking agents
Osmotic laxatives
The capacity of the intestine to absorb some molecules and ions, such as magnesium salts, is limited. Other molecules, such as lactulose and sorbitol, are completely unabsorbed. To maintain an iso-osmolar state, these substances draw water The non-absorbable sugars are fermented in the colon so they can cause bloating, distension and flatulence which may limit their use. They should not be used by people with diabetes.
Long-term use of magnesium salts is not recommended, particularly in patients with renal impairment.
Another approach is the use of large osmotically active polymers such as polyethylene glycol (PEG or macrogol). They are made iso-osmolar with intestinal contents so the water ingested with them is retained in the gut. The polymers are not absorbed, making them more suitable for long-term use in low volume. They can be used if simpler measures are ineffective, and are also used to prepare patients for colonoscopy.
Stimulant laxatives
Stimulant laxatives are often combined with stool softeners and may be useful in patients with poor colonic motility.
Diphenylmethane derivatives inhibit water absorption after activation, by endogenous esterases in the case of bisacodyl, or by colonic flora in the case of sodium picosulfate. These laxatives can precipitate cramping and electrolyte wasting. 
Stool softeners and lubricants
Methylnaltrexone
Methylnaltrexone is a peripherally acting mu opioid receptor antagonist. It is administered subcutaneously, and is used in patients with opioid-induced constipation. It is only approved for use in the setting of palliation, and is contraindicated in malignant bowel obstruction.
Pregnancy
Constipation is a common problem in pregnancy and iron supplements may also contribute to this. Fibre supplements, bisacodyl, lactulose and docusate all have reliable safety and efficacy in pregnancy. Although stimulant laxatives have been shown to be more effective, there is less certainty about their safety.
Conclusion
When non-pharmacological measures fail, consider prescribing a bulking agent. If this does not help then one of the osmotic laxatives can be tried, although there is little evidence to guide therapy, and there are failures with all approaches. The dose of laxative may need to be titrated to balance the benefit with any adverse effects. Long-term therapy with bulking agents, polyethylene glycol or lactulose is considered to be safe.
Stimulant laxatives can be used either alone or in combination with osmotic laxatives in patients with resistant chronic constipation. Long-term stimulant laxatives are avoided as they may induce melanosis coli, tolerance or cathartic colon and there is little evidence for their efficacy.
Treatment refractory constipation should prompt reconsideration of secondary causes. Referral to specialist services and physiological testing may be needed.
